Advertisement
New Zealand markets open in 4 hours 48 minutes
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5947
    +0.0010 (+0.17%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • OIL

    82.46
    -0.35 (-0.42%)
     
  • GOLD

    2,340.30
    +1.90 (+0.08%)
     

Top Research Reports for Intel, Verizon & Honeywell

Top Research Reports for Intel, Verizon & Honeywell

Monday, July 30, 2018

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Intel (INTC), Verizon (VZ) and Honeywell (HON). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Strong Buy-ranked Intel’s shares have underperformed the Zacks General Semiconductor industry over the past year, gaining +34.4% vs. +41.2%. Intel reported stellar second-quarter results. Both revenues and earnings increased year over year, on the back of impressive results from the Data Center Group, Internet-of-Things Group, Non-Volatile Memory Solutions and Programmable Solutions Group.

ADVERTISEMENT

These segments along with MobilEye form the crux of Intel’s data-centric business model. The Zacks analyst likes the company’s strategy of expanding TAM beyond CPU to adjacent product lines like silicon photonics, fabric, network ASICs, and 3D XPoint memory. Its expanding customer base in the PSG segment drove top-line growth. A stable PC market is also positive for the company.

Additionally, lower spending helped in expanding operating margins. Intel raised 2018 guidance based on these solid growth trends. However, delay in transition to 10-nm process is a concern. Moreover, intensifying competition remains a headwind.

(You can read the full research report on Intel here >>>).

Shares of Verizon have gained +7.5% over the last year, outperforming the Zacks Wireless National industry’s loss of -10.1% during the same period. Verizon reported strong second-quarter 2018 results beating both top- & bottom-line estimates.

The company expects healthy improvement in margins on the back of the expected savings from tax reform as well as continued strong FiOS fiber-optic network and strategic services in the Wireline business. Verizon plans to launch next-generation 5G wireless residential broadband services in three to five U.S. markets in 2018.

However, the company continues to struggle in a highly competitive and saturated wireless market, where spectrum crunch has become a major issue. Losses in wireline access lines and competitive video market remain major impediments. Verizon’s wireline division is also struggling with persistent losses in access lines owing to competitive pressure from VoIP service providers and aggressive triple-play offerings by cable companies.

(You can read the full research report on Verizon here >>>).

Honeywell’s shares have outperformed the Zacks Diversified Operations industry in the last year, increasing +17.1% vs. a -9.3% decline. The company reported better-than-expected second-quarter 2018 results. The company's top-line performance improved 6%, year over year, organically. Honeywell believes sturdier demand for its innovative technology solutions will continue to drive the company's segmental revenues in the quarters ahead.

Stronger sales volumes, increased productivity and ongoing commercial effectiveness actions will like drive near-term profitability. The company is currently facing inflationary headwinds across its entire supply-chain process. Inflation in logistics, transportation and in certain material prices might continue to weigh over Honeywell's profitability in the upcoming quarters.

(You can read the full research report on Honeywell here >>>).

Other noteworthy reports we are featuring today include Qualcomm (QCOM), Bristol-Myers (BMY) and BlackRock (BLK).

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>

Mark Vickery

Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Intel (INTC) Rides on AI-based Alliances & Product Rollouts

Verizon (VZ) Poised to Improve Margins, Competitive Woes Deter

Honeywell (HON) Braves Cost Woes with Robust Volume Growth

Featured Reports

Project Investments Drive Air Products (APD) Amid Cost Worries

While Air Products faces headwind from higher maintenance outage costs, it will gain from strong project backlog and strategic investments in high-return projects, per the Zacks analyst.

Suncor (SU) Buoyed by Fort Hills Amid Syncrude Concerns

While the impressive production ramp-up at its Fort Hills oil sands mining facility bodes well for Suncor, the Zacks analyst is worried over unplanned outages at the Syncrude joint venture.

End-Market Strength, Portfolio Expansion Aid Amphenol (APH)

Per the Zacks analyst, end-market strength particularly in the industrial, commercial aerospace and military sectors bodes well for Amphenol.

Restructuring Efforts Aid BlackRock (BLK), High Costs a Woe

Per the Zacks analyst, BlackRock is poised for revenue growth, driven by efforts to restructure its active equity business.

Hilton (HLT) Rides on Unit Expansion Amid Stiff Competition

Per the Zacks analyst, Hilton's relentless expansion strategy by year-over-year net unit growth is the major topline driver.

Strong Backlog & New Orders Aids Praxair (PX) Amid Inflation

Per the Zacks analyst, Praxair will gain from three new onsite projects and China National Offshore Oil Corporation project.

Growing Topline Aids Marsh & McLennan (MMC), Expenses Hurt

Per the Zacks analyst, increasing topline driven by product offerings, geographic expansion and acquisitions has led to significant growth.

New Upgrades

Qualcomm (QCOM) Poised to Benefit from Core Business Focus

Per the Zacks analyst, Qualcomm aims to gain headway in 5G, chipset market and mobile connectivity with technological expertise, while eliminating the business uncertainty by aborting NXP deal.

Freight Revenues, Dividends Boost Canadian National (CNI)

The Zacks analyst likes the growth in freight revenues, on the back of strong demand. Efforts to reward shareholders through dividends and buybacks are encouraging.

Opdivo's Expanded Label, Eliquis Fuel Bristol-Myers (BMY)

Per the Zacks analyst, strong performance of blockbuster drug Opdivo for new indications are boosting sales. Eliquis is expected to drive growth on the back of increases in market share.

New Downgrades

Higher Costs, Concentration Risk Hurt Raymond James (RJF)

Per the Zacks analyst, rising expenses due to higher compensation costs will hurt Raymond James' profits. Concentration risk arising from significant dependence on U.S. revenues is also a woe.

Temperature Control Segment Drags Standard Motor (SMP) Lower

Per the Zacks analyst, cool summer has adversely hit sales of Standard Motor's Temperature Control segment. Also, heavier than normal inventories is restricting new orders.

ServiceNow (NOW) Hurt by Accumulated Deficit & Competition

Per the Zacks analyst, stiff competition in non-ITSM product segments, modest growth in professional business, continuing losses, muted free cash flow growth and stretched valuation are key negatives.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Verizon Communications Inc. (VZ) : Free Stock Analysis Report
 
QUALCOMM Incorporated (QCOM) : Free Stock Analysis Report
 
Intel Corporation (INTC) : Free Stock Analysis Report
 
Honeywell International Inc. (HON) : Free Stock Analysis Report
 
Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report
 
BlackRock, Inc. (BLK) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research